Efficacy of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) in targeted therapy of lung squamous cell carcinoma patients with EGFR mutation: a pooled analysis

PURPOSE: This pooled analysis aims to evaluate the efficacy of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) in lung squamous cell carcinoma with EGFR mutation. METHODS: Advanced stage (IIIB/IV) lung squamous cell carcinoma patients with EGFR mutations treated with EGFR-T...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Jingqi, Yu, Yongfeng, Li, Ziming, Lu, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581140/
https://www.ncbi.nlm.nih.gov/pubmed/28881841
http://dx.doi.org/10.18632/oncotarget.15726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581140/
https://www.ncbi.nlm.nih.gov/pubmed/28881841
http://dx.doi.org/10.18632/oncotarget.15726

Ejemplares similares